What Is Abivax SA (ABVX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Abivax SA's intrinsic value is estimated at $39.09, suggesting the stock is overvalued at its current price of $135.98. With 8 out of 9 models flagging downside (-71.3% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: PWERM targets $134.52 (-1.1%), versus Regime Cross at $0.01 (-100.0%). This +98.9% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About ABVX?
9 of 13 models are currently active for ABVX. All 9 active models suggest the stock trades above fair value. The Bayesian DCF estimates ABVX's intrinsic value at $63.61, implying -53.2% downside from the current price. See which stocks rank higher →
How Does ABVX Rank in Biotechnology?
Among 62 Biotechnology stocks, ABVX ranks #23 by Quality of Company score. CirclFi's QOC score of 5.5/10 evaluates 32 fundamental signals. A score of 5.5 reflects mixed fundamentals.
See all Most Undervalued Biotechnology Stocks →
As a biotechnology enterprise, Abivax SA operates in a sector where pipeline depth and stage distribution is a critical driver of valuation. Investors evaluating ABVX should weigh these sector-specific dynamics alongside our model-derived fair values.
Is ABVX a Value Trap?
CirclFi's Value Trap algorithm assigns ABVX a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for Abivax SA. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Abivax SA's fundamental quality profile registers 5.5/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +98.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ABVX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ABVX's 9 active models, average confidence is 32%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad